Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LXRX | DSGN | GYRE | ||
| Company | Lexicon Pharmaceutcl | Design Therapeutics Inc | Gyre Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.8500 | 13.16 | 8.00 | ||
| High | 1.8900 | 13.54 | 8.09 | ||
| Low | 1.7900 | 12.81 | 7.86 | ||
| Latest | 1.8300 | 13.29 | 7.87 | ||
| Change | -0.0100 | +0.13 | -0.07 | ||
| % Change | -0.54% | +0.99% | -0.88% | ||
| Volume | 1,402,000 | 453,700 | 68,800 | ||
| 20-Day Average Volume | 2,232,060 | 303,975 | 76,395 | ||
| Previous Close | 1.8400 | 13.16 | 7.94 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.7010 | 11.87 | 7.37 | ||
| 20-Day Raw Stochastic | 73.91% | 93.13% | 76.92% | ||
| 20-Day Relative Strength | 59.84 | 67.68 | 54.14 | ||
| Weighted Alpha | +193.40 | +266.81 | -4.71 | ||
| Today's Opinion | 100% Buy | 100% Buy | 48% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 48% Buy | ||
| Last Month's Opinion | 88% Buy | 88% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.57% since 04/14/26 | +5.14% since 04/14/26 | +0.38% since 04/14/26 | ||
| Low | 1.7400 on 04/15/26 | 12.20 on 04/16/26 | 7.81 on 04/16/26 | ||
| High | 1.9500 on 04/17/26 | 13.54 on 04/21/26 | 8.20 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | +17.31% since 03/20/26 | +28.90% since 03/20/26 | +17.11% since 03/20/26 | ||
| Low | 1.4900 on 03/30/26 | 9.90 on 03/24/26 | 6.77 on 03/30/26 | ||
| High | 1.9500 on 04/17/26 | 13.54 on 04/21/26 | 8.20 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | +17.31% since 01/21/26 | +39.16% since 01/21/26 | -5.18% since 01/21/26 | ||
| Low | 1.1000 on 01/30/26 | 9.53 on 01/22/26 | 6.58 on 03/20/26 | ||
| High | 1.9500 on 04/17/26 | 13.54 on 04/21/26 | 9.14 on 03/05/26 | ||
| 6-Month | |||||
| %Chg | +27.08% since 10/21/25 | +136.06% since 10/21/25 | -5.41% since 10/21/25 | ||
| Low | 1.1000 on 01/30/26 | 5.28 on 10/22/25 | 6.58 on 03/20/26 | ||
| High | 1.9500 on 04/17/26 | 13.54 on 04/21/26 | 9.14 on 03/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 779,573 | 811,604 | 770,132 | ||
| Shares Outstanding, K | 423,681 | 61,672 | 96,994 | ||
| Annual Sales | 49,800,000 | 0 | 116,590,000 | ||
| Annual Net Income | -50,340,000 | -69,790,000 | 5,030,000 | ||
| Last Quarter Sales | 5,490,000 | 0 | 37,200,000 | ||
| Last Quarter Net Income | -15,530,000 | -16,000,000 | -1,720,000 | ||
| 60-Month Beta | 0.94 | 1.57 | 2.10 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.04 on 03/05/26 | -0.27 on 03/09/26 | 0.04 on 03/12/26 | ||
| Latest Earnings Date | 05/12/26 | 05/06/26 | 05/08/26 | ||
| Most Recent Dividend | N/A | N/A | 0.569 on 08/20/15 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 73.64 | ||